Efficacy and safety of donepezil for mild cognitive impairment: A systematic review and meta-analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of donepezil for mild cognitive impairment: A systematic review and meta-analysis
Authors
Keywords
Mild cognitive impairment, Donepezil, Meta-analysis, Efficacy, Safety
Journal
CLINICAL NEUROLOGY AND NEUROSURGERY
Volume 213, Issue -, Pages 107134
Publisher
Elsevier BV
Online
2022-01-20
DOI
10.1016/j.clineuro.2022.107134
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Proportion of APOE4 Carriers Among Non-Demented Individuals: A Pooled Analysis of 389,000 Community-Dwellers
- (2021) Ya-Yu Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Efficacy and Safety of Cholinesterase Inhibitors for Mild Cognitive Impairment:A Systematic Review and Meta-Analysis
- (2019) Shinji Matsunaga et al. JOURNAL OF ALZHEIMERS DISEASE
- Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial
- (2018) Davangere P. Devanand et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Donepezil for gait and falls in mild cognitive impairment: a randomized controlled trial
- (2018) M. Montero-Odasso et al. EUROPEAN JOURNAL OF NEUROLOGY
- Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment
- (2017) Sophie Sokolow et al. JOURNAL OF ALZHEIMERS DISEASE
- Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer’s Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects
- (2016) Louis De Beaumont et al. JOURNAL OF ALZHEIMERS DISEASE
- Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer's disease
- (2015) Bruno Dubois et al. Alzheimers & Dementia
- Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer’s Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials
- (2015) Taro Kishi et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Maintenance Treatment of Depression in Old Age
- (2011) Charles F. Reynolds et al. ARCHIVES OF GENERAL PSYCHIATRY
- Short latency afferent inhibition differs among the subtypes of mild cognitive impairment
- (2011) Raffaele Nardone et al. JOURNAL OF NEURAL TRANSMISSION
- An MRI substudy of a donepezil clinical trial in mild cognitive impairment
- (2010) Norbert Schuff et al. NEUROBIOLOGY OF AGING
- Donepezil delays progression to AD in MCI subjects with depressive symptoms
- (2009) P. H. Lu et al. NEUROLOGY
- Donepezil treatment of patients with MCI: A 48-week randomized, placebo-controlled trial
- (2009) R. S. Doody et al. NEUROLOGY
- Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis
- (2008) A J Mitchell et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started